Kona Hospital
Kona Hospital was paid $22.27M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
KEALAKEKUA, HI 96750
Next to other General Acute Care Hospital providers in Hawaii
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,873 | $3.82M | |
| 2019 | 48,896 | $3.46M | |
| 2020 | 28,444 | $2.00M | |
| 2021 | 36,779 | $2.52M | |
| 2022 | 39,227 | $2.84M | |
| 2023 | 42,256 | $3.47M | |
| 2024incomplete | 40,996 | $4.16M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 15,507 | 13,861 | $6.90M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 17,156 | 15,889 | $5.68M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 6,251 | 5,551 | $3.57M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.3% | 2,632 | 2,461 | $2.06M |
| G0378 | Hospital observation service, per hour | 4.3% | 1,724 | 1,480 | $949K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 3,187 | 3,059 | $778K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.4% | 775 | 713 | $527K |
| 41899 | Unlisted procedure, dentoalveolar structures | 2.1% | 580 | 563 | $475K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 348 | 314 | $257K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 964 | 923 | $166K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,441 | 3,127 | $125K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 653 | 621 | $113K |
148 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 4,046 | $108K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 484 | $101K |
| 59025 | Fetal non-stress test | <1% | 1,533 | $74K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,960 | $64K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,865 | $53K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 165 | $50K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 25 | $29K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 353 | $23K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,144 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,735 | $19K |
| 59020 | <1% | 163 | $15K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 198 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,916 | $10K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 259 | $9K |
| J3490 | Unclassified drugs | <1% | 87 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,774 | $6K |
| 96160 | <1% | 4,569 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 56 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 545 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,836 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 73 | $5K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 942 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,085 | $4K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 77 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 16,264 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,725 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,510 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,640 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,512 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 192 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,764 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 16 | $1K |
| 83880 | <1% | 1,470 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 58 | $1K |
| 84484 | <1% | 5,138 | $1K | |
| 73630 | <1% | 587 | $922.99 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 461 | $839.64 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 126 | $722.00 |
| 87186 | <1% | 1,611 | $697.19 | |
| 84703 | <1% | 4,968 | $642.25 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,179 | $582.47 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,553 | $573.47 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,068 | $535.38 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 186 | $522.99 |
| 81001 | <1% | 11,739 | $500.91 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,139 | $500.25 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,666 | $491.05 |
| 83690 | <1% | 4,612 | $361.03 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 173 | $340.76 |
| 87040 | <1% | 2,562 | $337.78 | |
| 90715 | <1% | 632 | $319.50 | |
| 83605 | <1% | 2,311 | $263.66 | |
| 73130 | <1% | 214 | $258.03 | |
| 96161 | <1% | 1,142 | $235.62 | |
| 73610 | <1% | 138 | $231.57 | |
| 73030 | <1% | 92 | $226.24 | |
| 83735 | <1% | 3,077 | $220.48 | |
| 86900 | <1% | 1,681 | $205.23 | |
| 85379 | <1% | 705 | $196.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,217 | $167.23 |
| 96376 | <1% | 1,024 | $165.64 | |
| 94761 | <1% | 573 | $163.94 | |
| 87077 | <1% | 1,605 | $159.31 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,175 | $158.69 |
| 73110 | <1% | 64 | $151.07 | |
| 73562 | <1% | 172 | $147.68 | |
| 86901 | <1% | 1,679 | $146.42 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,427 | $143.54 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 357 | $116.90 |
| 84702 | <1% | 512 | $113.01 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,851 | $109.71 |
| 76801 | <1% | 27 | $101.55 | |
| 80305 | <1% | 1,544 | $89.37 | |
| 93971 | <1% | 12 | $89.23 | |
| 96367 | <1% | 340 | $87.62 | |
| 85730 | <1% | 2,068 | $82.76 | |
| 85610 | <1% | 3,006 | $72.88 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,895 | $62.58 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 612 | $56.85 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,756 | $55.81 |
| 87634 | <1% | 15 | $55.46 | |
| 82962 | <1% | 3,336 | $52.09 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 904 | $45.63 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,165 | $45.16 |
| 86850 | <1% | 1,157 | $42.17 | |
| 80076 | <1% | 222 | $41.46 | |
| 93041 | <1% | 1,618 | $35.64 | |
| A9270 | Non-covered item or service | <1% | 3,388 | $33.57 |
| 87081 | <1% | 497 | $30.43 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,363 | $26.07 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 864 | $25.83 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 245 | $21.50 |
| 73080 | <1% | 16 | $20.64 | |
| 74018 | <1% | 83 | $19.68 | |
| 85027 | <1% | 667 | $19.34 | |
| 85651 | <1% | 333 | $17.05 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 29 | $16.86 |
| 87070 | <1% | 188 | $16.17 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 774 | $14.59 |
| 87088 | <1% | 185 | $14.17 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,158 | $12.46 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,456 | $11.57 |
| 86140 | <1% | 500 | $11.12 | |
| 82550 | <1% | 15 | $9.61 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 371 | $9.46 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,083 | $8.90 |
| 81025 | <1% | 201 | $7.83 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,626 | $7.42 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 27 | $6.36 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 754 | $5.14 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,615 | $4.77 |
| 81003 | <1% | 274 | $3.92 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 137 | $0.34 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 385 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 94 | $0.00 |
| 0240U | 0% | 31 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 71 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 16 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 625 | $0.00 |
| 70486 | 0% | 13 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 37 | $0.00 |
| 80329 | 0% | 64 | $0.00 | |
| 80320 | 0% | 35 | $0.00 | |
| 85652 | 0% | 31 | $0.00 | |
| 12002 | 0% | 12 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
| 96368 | 0% | 16 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 194 | $0.00 |
| 73140 | 0% | 12 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 160 | $0.00 |
| 10060 | 0% | 39 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 32 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 29 | $0.00 |
| 72100 | 0% | 24 | $0.00 | |
| 84100 | 0% | 50 | $0.00 | |
| 82805 | 0% | 58 | $0.00 | |
| 80143 | 0% | 18 | $0.00 | |
| 80179 | 0% | 18 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 19 | $0.00 |
| A4565 | Slings | 0% | 14 | $0.00 |
| 84145 | 0% | 54 | $0.00 | |
| 93017 | 0% | 12 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 15 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 13 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 23 | $0.00 |
| 73590 | 0% | 15 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Adventist Healthcare, INC. | Rockville, MD | $9.70M |
| Adventist Healthcare, INC. | Silver Spring, MD | $4.50M |
| Adventist Healthcare Urgent Care Centers INC | Rockville, MD | $1.56M |
| Pure Dental, PC | Flushing, NY | $1.24M |
| Access Home Medical LLC | Sumter, SC | $520K |
| Adventist Rehabilitation Hospital of Maryland INC | Rockville, MD | $470K |
| James Lee MD PC | Colorado Springs, CO | $450K |
| Peak Surgery Center LLC | Colorado Springs, CO | $36K |
| Ascension Behavioral Healthcare, P.A. | Rock Hill, SC | $23K |
| Heartcare, PC | Cullman, AL | $8K |
| DR Keith Lee-Integrative Mental Health, LLC | Owensboro, KY | $6K |
| Ent & Allergy Specialists of Virginia PC | Ashburn, VA | $1K |
| Outpatient Biopsy Center | Alhambra, CA | $430.63 |
| Adventist Healthcare, INC. | Rockville, MD | $0.00 |
| Vascular Center of Intervention, INC. | Fresno, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.